Update shared on 28 Oct 2025
Fair value Increased 2.30%Analysts have raised their price target for MCB Bank from Rs 380 to Rs 388.75, citing improved profit margins and a more favorable discount rate as key factors behind the upward revision.
What's in the News
- Board Meeting scheduled on October 22, 2025 to consider quarterly financial results for the period ended September 30, 2025 and potential entitlements (Key Developments)
- Board Meeting held on August 6, 2025 to approve half yearly financial statements for the period ended June 30, 2025 and discuss any entitlements (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has increased from PKR 380 to PKR 388.75, reflecting a modest upward adjustment.
- Discount Rate has fallen from 31.98% to 30.54%, indicating a slightly more favorable financing environment.
- Revenue Growth estimate has improved marginally, changing from negative 6.10% to negative 5.18%.
- Net Profit Margin has risen from 37.46% to 38.87%, suggesting better profitability expectations.
- Future P/E has dropped significantly from 21.61 times to 15.25 times, pointing to a lower valuation relative to projected earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.